100367-74-6

Basic information

• Product Name: 4-bromo-2-methylpyridine 1-oxide
• Synonyms: 4-bromo-2-methylpyridine 1-oxide
• CAS NO: 100367-74-6
• Molecular Formula: C₆H₆BrNO
• Molecular Weight: 188.03
• Mol File: 100367-74-6.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 178 °C(Press: 14 Torr)
• Appearance: /
• Density: 1.56±0.1 g/cm3(Predicted)
• PKA: 1.04±0.10(Predicted)
• CAS DataBase Reference: 4-bromo-2-methylpyridine 1-oxide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-bromo-2-methylpyridine 1-oxide(100367-74-6)
• EPA Substance Registry System: 4-bromo-2-methylpyridine 1-oxide(100367-74-6)

Safety Data

• Hazardous Substances Data: 100367-74-6(Hazardous Substances Data)

Usage

General Description

4-bromo-2-methylpyridine 1-oxide is a chemical compound with the molecular formula C6H6BrNO. It is a pyridine derivative with a bromine atom and a methyl group attached to the pyridine ring. The "1-oxide" in its name indicates the presence of an oxygen atom on the first carbon of the pyridine ring. 4-bromo-2-methylpyridine 1-oxide is commonly used as a building block in organic synthesis and pharmaceutical research. It can also serve as a precursor for the synthesis of various heterocyclic compounds and is utilized in the development of pharmaceuticals, agrochemicals, and materials with potential biological activities. Additionally, it has applications in the field of medicinal chemistry and drug discovery as a key intermediate in the preparation of target molecules for drug development.

Upstream product

• 22282-99-1 4-bromo-2-methylpyridine 
• 5470-66-6 2-methyl-4-nitropyridine N-oxide 
• 506-96-7 Acetyl bromide 
• 18437-58-6 3-methyl-4-pyridinamine 

Downstream Products

• 192642-94-7 acetic acid 4-bromopyridin-2-ylmethyl ester 
• 865156-50-9 1-(4-bromopyridin-2-yl)methanamine 
• 959756-37-7 acetic acid 4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)pyridin-2-ylmethyl ester 
• 131747-45-0 4-bromo-2-(hydroxymethyl)pyridine 

Relevant articles and documents

Human carbonic anhydrase II as host protein for the creation of artificial metalloenzymes: The asymmetric transfer hydrogenation of imines

In the presence of human carbonic anhydrase II, aryl-sulfonamide-bearing IrCp* pianostool complexes catalyze the asymmetric transfer hydrogenation of imines. Critical cofactor-protein interactions revealed by the X-ray structure of [(η5-Cp*)Ir(pico 4)Cl] 9 WT hCA II were genetically optimized to improve the catalytic performance of the artificial metalloenzyme (68% ee, kcat/KM 6.11 × 10 -3 min-1 mM-1).

ANALOGS OF 2-PRALIDOXIME AS ANTIDOTES AGAINST ORGANOPHOSPHORUS NERVE AGENTS

Provided herein are compounds useful in treating exposure to an organophosphorus compound, such as a nerve agent, pesticide, or, generally, an acetylcholinesterase inhibitor, such as sarin. Compositions, e.g. pharmaceutical compositions or dosage forms, comprising the compounds also are provided herein. Methods of treating a patient exposed to a nerve agent, pesticide, or, generally, an acetylcholinesterase inhibitor, e.g., an organophosphorus compound, such as sarin, also are provided.

MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF

Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with methyl modifying enzymes. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with methyl modifying enzymes.

Anchoring a molecular iron catalyst to solar-responsive WO3 improves the rate and selectivity of photoelectrochemical water oxidation

Molecular catalysts help overcome the kinetic limitations of water oxidation and generally result in faster rates for water oxidation than do heterogeneous catalysts. However, molecular catalysts typically function in the dark and therefore require sacrificial oxidants such as Ce4+ or S2O82- to provide the driving force for the reaction. In this Communication, covalently anchoring a phosphonate-derivatized complex, Fe(tebppmcn)Cl2 (1), to WO3 removes the need for a sacrificial oxidant and increases the rate of photoelectrochemical water oxidation on WO3 by 60%. The dual-action catalyst, 1-WO3, also gives rise to increased selectivity for water oxidation in pH 3 Na 2SO4 (56% on bare WO3, 79% on 1-WO 3). This approach provides promising alternative routes for solar water oxidation.